CADMF Stock Price, News & Analysis
Company Description
CADMF (OTC: CADMF) is a publicly traded drug manufacturers—specialty & generic company in the Healthcare sector. The company has a market capitalization of $4.2M.
CADMF stock has declined 76.2% over the past year.
This page provides a comprehensive overview of CADMF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
CADMF (CADMF) stock. Over the past 12 months, the stock has lost 76.2%. At a market capitalization of $4.2M, CADMF is classified as a micro-cap stock with approximately 56.2M shares outstanding.
Latest News
CADMF has 10 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. Key topics include partnership. View all CADMF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
CADMF Company Profile & Sector Positioning
CADMF (CADMF) operates in the Drug Manufacturers—Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing CADMF often look at related companies in the same sector, including CHINA INFRASTRUCTURE CONSTRUCTI (CHNC), (CADMD), (ATNX), Vencanna Ventures (TPPRF), and Mallinckrodt Plc (MNKKQ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CADMF's relative position within its industry.